Intersect ENT to Participate in Upcoming Investor Conferences
MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to...
Day: February 1, 2021
Hologic and Google Cloud Announce Collaboration to Advance Next Generation Digital Diagnostic Capabilities
New agreement to focus on enhancing artificial intelligence and machine learning to bring about breakthrough results in cervical cancer screening...
Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2020 Financial Results and Conference Call
MINNEAPOLIS, MN / ACCESSWIRE / February 1, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical stage biotechnology company translating discoveries of...
Pharnext Provides an Update on its Pivotal Clinical Development Program in Charcot-Marie-Tooth Disease Type 1A (‘CMT1A’)
PARIS, FRANCE / ACCESSWIRE / February 1, 2021 / 6:00 p.m. CET - Pharnext SA (FR0011191287 - ALPHA) (the 'Company'),...
Innovative Product ExoFlo™ Fulfills Unmet but Urgent Medical Need in COVID-19 Treatment
Medical professionals report dramatic and consistent success in treating patients gravely ill with COVID-19-associated Acute Respiratory Distress Syndrome (ARDS) Treatment...
Aetna International introduces new mental health benefits to its core offering
Updates to Summit and Pioneer plans include enhanced mental health and well-being cover and support to help address the ongoing...
Ketamine Taskforce for Access to Safe Care and Insurance Coverage Launches, Offering Hope to Chronic Pain and Mental Health Patients
Real-world evidence, powered by tech partner Osmind, is providing efficacy data from ketamine practices and patients to back the Taskforce’s...
Dynatronics Corporation Schedules Conference Call to Report Results for Second Quarter of Fiscal Year 2021
EAGAN, MN / ACCESSWIRE / February 1, 2021 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,...
World High Life PLC Announces Total Voting Rights
LONDON, UK / ACCESSWIRE / February 1, 2021 / World High Life PLC ("World High Life" or the "Company") (LSE:LIFE)(OTCQB:WRHLF): For the...
Nationwide Medication Savings Leader Prescription Hope is Helping People Achieve their New Year’s Resolution to Save Money
STUART, FL / ACCESSWIRE / February 1, 2021 / Prescription Hope, one of the largest patient assistance program administrators in...
How Advancements of extracorporeal life support technology is Spurring Growth of Centrifugal blood pump Market: New Report Analyses
Key market players are aiming at strategic alliances with service providers to address the requirements of an expanding patient base....
Halberd Corporation’s CEO Interviewed on The Stock Day Podcast and on MoneyTV
JACKSON CENTER, PA / ACCESSWIRE / February 1, 2021 / Halberd Corporation's (OTC PINK:HALB) Chairman, President & CEO, William A....
ENB Therapeutics Demonstrated Early Efficacy in Phase I Clinical Trial of ENB-003 in Combination with Pembrolizumab
ENB-003 is the Company's first in class small molecule therapeutic selectively targeting the ETB receptor - a novel immune checkpoint...
9 Meters Biopharma, Inc. Announces Research & Development Day on Short Bowel Syndrome
SAVE THE DATE: Webinar Scheduled for March 23, 2021 @ 11 AM ET RALEIGH, NC / ACCESSWIRE / February 1,...
Kadmon Announces Publication of Preclinical Data Demonstrating Anti-PD-L1/IL-15 Fusion Protein KD033 Achieves Robust Anti-Tumor Response
NEW YORK, NY / ACCESSWIRE / February 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced the publication of preclinical...
Pharma-Bio Serv Announces Results for the Year Ended October 31, 2020
DORADO, PUERTO RICO / ACCESSWIRE / February 1, 2021 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), is...
Theralase(R) Releases Quarterly Newsletter
TORONTO, ON / ACCESSWIRE / February 1, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Sonnet BioTherapeutics Completes Successful Repeat Dose Study of SON-1010 in Non-Human Primates
The toxicity effects of SON-1010 were well tolerated at doses exceeding levels expected in future human clinical trials, without producing...
Lexaria Provides Guidance on Upcoming R&D
KELOWNA, BC / ACCESSWIRE / February 1, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator...
National Basketball Retired Players Association, Sheryl Swoopes and Flexion Therapeutics Announce Partnership to Raise Awareness of ZILRETTA®
- Sheryl Swoopes, WNBA Legend, Basketball Hall of Famer and ZILRETTA Patient, Tips Off Educational Campaign About ZILRETTA and Osteoarthritis Knee...